Literature DB >> 20556271

Synthesis and biological evaluation of amphotericin B derivatives.

Astrid A Volmer1, Alex M Szpilman, Erick M Carreira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20556271     DOI： 10.1039/b820743g

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN： 0265-0568            Impact factor:   13.423


× No keyword cloud information.
  28 in total

1.  Amphotericin primarily kills yeast by simply binding ergosterol.

Authors:  Kaitlyn C Gray; Daniel S Palacios; Ian Dailey; Matthew M Endo; Brice E Uno; Brandon C Wilcock; Martin D Burke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.

Authors:  Ana Cecilia Mesa-Arango; Nuria Trevijano-Contador; Elvira Román; Ruth Sánchez-Fresneda; Celia Casas; Enrique Herrero; Juan Carlos Argüelles; Jesús Pla; Manuel Cuenca-Estrella; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 3.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

4.  Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine.

Authors:  Audrey E Yñigez-Gutierrez; Brian O Bachmann
Journal:  J Med Chem       Date:  2019-04-26       Impact factor: 7.446

5.  Late-stage chemoselective functional-group manipulation of bioactive natural products with super-electrophilic silylium ions.

Authors:  Trandon A Bender; Philippa R Payne; Michel R Gagné
Journal:  Nat Chem       Date:  2017-09-18       Impact factor: 24.427

6.  Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.

Authors:  Joanna Boros-Majewska; Natalia Salewska; Edward Borowski; Sławomir Milewski; Sladjana Malic; Xiao-Qing Wei; Anthony J Hayes; Melanie J Wilson; David W Williams
Journal:  Med Microbiol Immunol       Date:  2014-06-13       Impact factor: 3.402

7.  Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study.

Authors:  Heba A Mohamed; Rasha R Radwan; Amany I Raafat; Amr El-Hag Ali
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

8.  A new look at the antibiotic amphotericin B effect on Candida albicans plasma membrane permeability and cell viability functions.

Authors:  Barbara Chudzik; Mateusz Koselski; Aleksandra Czuryło; Kazimierz Trębacz; Mariusz Gagoś
Journal:  Eur Biophys J       Date:  2015-01-04       Impact factor: 1.733

9.  C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells.

Authors:  Brandon C Wilcock; Matthew M Endo; Brice E Uno; Martin D Burke
Journal:  J Am Chem Soc       Date:  2013-06-03       Impact factor: 15.419

10.  Taming Amphotericin B.

Authors:  Vaclav Janout; Wiley A Schell; Damien Thévenin; Yuming Yu; John R Perfect; Steven L Regen
Journal:  Bioconjug Chem       Date:  2015-09-10       Impact factor: 4.774
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.